Signaling Pathways - Bladder Carcinoma - Hypercholesterolemia - Myelofibrosis
清除全部
- B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂
- A3573 LY2801653Target: METSummary: MET抑制剂
- A3419 Fluvastatin中文名: 氟伐他汀Target: HMGCRSummary: HMGCR抑制剂
- A4375 Anacetrapib (MK-0859)1 Citation中文名: 安塞曲匹Target: CETPSummary: RhCETP/突变型 CETP(C13S) 抑制剂
- A4367 Atorvastatin Calcium中文名: 阿托伐他汀钙Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂
- A4365 Lovastatin中文名: 洛伐他汀Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂
- A1915 Zebularine1 Citation中文名: 泽布拉林Target: DNA Methyltransferases|Cytidine deaminasesSummary: DNA甲基化抑制剂
- A4212 Pomalidomide (CC-4047)中文名: 泊马度胺Summary: 抗肿瘤/抗血管生成的免疫调制剂
- A4136 TG101348 (SAR302503)2 Citation中文名: 费德拉替尼Target: FLT3|JAK|c-RETSummary: JAK-2抑制剂